Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 79.59% is in line with its 5-year average of 78.61%, near the high end of its 5-year range (63.74%–83.52%).
0.21% above its 12-month average of 79.42%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
79.59%
GROSS MARGIN AVG TTM
79.42%
GROSS MARGIN AVG 3Y
78.57%
GROSS MARGIN AVG 5Y
78.61%
GROSS MARGIN AVG 10Y
80.12%
GROSS MARGIN AVG 15Y
79.82%
GROSS MARGIN AVG 20Y
79.74%
CURRENT VS TTM AVG
+0.21%
CURRENT VS 3Y AVG
+1.30%
CURRENT VS 5Y AVG
+1.24%
CURRENT VS 10Y AVG
-0.66%
CURRENT VS 15Y AVG
-0.29%
CURRENT VS 20Y AVG
-0.19%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+34.91%
vs the sector median at left
Gilead Sciences, Inc.
Market Cap
$181.72B
Gross Margin
79.59%
TTM Avg
79.42%
3Y Avg
78.57%
5Y Avg
78.61%
Market Cap
$183.26B
Gross Margin
56.80%
TTM Avg
53.17%
3Y Avg
51.86%
5Y Avg
51.92%
Market Cap
$145.19B
Gross Margin
58.51%
TTM Avg
60.22%
3Y Avg
59.98%
5Y Avg
59.48%
Market Cap
$224.14B
Gross Margin
40.37%
TTM Avg
39.50%
3Y Avg
40.36%
5Y Avg
43.54%
Market Cap
$134.71B
Gross Margin
86.04%
TTM Avg
85.57%
3Y Avg
86.56%
5Y Avg
87.08%
Market Cap
$133.09B
Gross Margin
70.16%
TTM Avg
63.94%
3Y Avg
60.40%
5Y Avg
58.39%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | $181.72B | 79.59% | 79.42% | 78.57% | 78.61% |
| Abbott Laboratories (ABT)vs › | $183.26B | 56.80% | 53.17% | 51.86% | 51.92% |
| Novo Nordisk A/S (NVO)vs › | $202.07B | 80.64% | 82.83% | 83.54% | 83.48% |
| Pfizer Inc. (PFE)vs › | $159.04B | 71.32% | 68.05% | 62.23% | 63.06% |
| Amgen Inc. (AMGN)vs › | $214.73B | 72.65% | 66.16% | 69.53% | 71.51% |
| Danaher Corporation (DHR)vs › | $145.19B | 58.51% | 60.22% | 59.98% | 59.48% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $224.14B | 40.37% | 39.50% | 40.36% | 43.54% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.71B | 86.04% | 85.57% | 86.56% | 87.08% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.09B | 70.16% | 63.94% | 60.40% | 58.39% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.06B | 66.68% | 66.73% | 66.82% | 67.04% |
Gross Margin
79.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 79.76% |
| 2026-03-31 | 79.24% |
| 2025-12-31 | 79.51% |
| 2025-09-30 | 79.80% |
| 2025-06-30 | 78.80% |
| 2025-03-31 | 76.90% |
| 2024-12-31 | 79.11% |
| 2024-09-30 | 79.14% |
| 2024-06-30 | 77.79% |
| 2024-03-31 | 76.79% |
| 2023-12-31 | 70.62% |
| 2023-09-30 | 77.80% |
| 2023-06-30 | 78.15% |
| 2023-03-31 | 77.94% |
| 2022-12-31 | 81.11% |
| 2022-09-30 | 80.19% |
| 2022-06-30 | 76.96% |
| 2022-03-31 | 78.39% |
| 2021-12-31 | 63.74% |
| 2021-09-30 | 83.52% |
| 2021-06-30 | 77.64% |
| 2021-03-31 | 78.81% |
| 2020-12-31 | 81.16% |
| 2020-09-30 | 82.65% |
| 2020-06-30 | 79.31% |
| 2020-03-31 | 82.53% |
| 2019-12-31 | 71.37% |
| 2019-09-30 | 81.53% |
| 2019-06-30 | 82.41% |
| 2019-03-31 | 81.88% |
| 2018-12-31 | 72.91% |
| 2018-09-30 | 80.59% |
| 2018-06-30 | 78.82% |
| 2018-03-31 | 80.33% |
| 2017-12-31 | 78.89% |
| 2017-09-30 | 84.15% |
| 2017-06-30 | 84.23% |
| 2017-03-31 | 85.29% |
| 2016-12-31 | 85.31% |
| 2016-09-30 | 84.95% |
| 2016-06-30 | 88.89% |
| 2016-03-31 | 84.69% |
| 2015-12-31 | 87.51% |
| 2015-09-30 | 87.17% |
| 2015-06-30 | 87.89% |
| 2015-03-31 | 88.39% |
| 2014-12-31 | 85.47% |
| 2014-09-30 | 83.66% |
| 2014-06-30 | 85.85% |
| 2014-03-31 | 83.74% |
| 2013-12-31 | 72.51% |
| 2013-09-30 | 75.50% |
| 2013-06-30 | 75.26% |
| 2013-03-31 | 74.94% |
| 2012-12-31 | 73.89% |
| 2012-09-30 | 75.39% |
| 2012-06-30 | 74.33% |
| 2012-03-31 | 74.55% |
| 2011-12-31 | 73.44% |
| 2011-09-30 | 74.93% |
| 2011-06-30 | 75.02% |
| 2011-03-31 | 75.38% |
| 2010-12-31 | 75.17% |
| 2010-09-30 | 75.35% |
| 2010-06-30 | 76.36% |
| 2010-03-31 | 78.88% |
| 2009-12-31 | 76.71% |
| 2009-09-30 | 77.26% |
| 2009-06-30 | 76.75% |
| 2009-03-31 | 78.48% |
| 2008-12-31 | 77.49% |
| 2008-09-30 | 78.11% |
| 2008-06-30 | 79.21% |
| 2008-03-31 | 80.94% |
| 2007-12-31 | 80.31% |
| 2007-09-30 | 81.26% |
| 2007-06-30 | 82.53% |
| 2007-03-31 | 83.31% |
| 2006-12-31 | 82.73% |
| 2006-09-30 | 85.34% |
| 2006-06-30 | 88.64% |
| 2006-03-31 | 86.96% |
| 2005-12-31 | 87.83% |
| 2005-09-30 | 86.73% |
| 2005-06-30 | 87.23% |
| 2005-03-31 | 86.66% |
| 2004-12-31 | 86.82% |
| 2004-09-30 | 87.48% |
| 2004-06-30 | 86.83% |
| 2004-03-31 | 88.69% |
| 2003-12-31 | 87.37% |
| 2003-09-30 | 87.06% |
| 2003-06-30 | 86.56% |
| 2003-03-31 | 87.06% |
| 2002-12-31 | 86.52% |
| 2002-09-30 | 84.77% |
